Cargando…

Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use

PURPOSE: The database Pharmaceuticals and Environment is a non-commercial, freely available web-based decision support presenting compiled environmental information for pharmaceutical substances. It was developed by Region Stockholm and launched in 2016 at janusinfo.se. The purpose of this paper is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramström, Helena, Martini, Siv, Borgendahl, Johanna, Ågerstrand, Marlene, Lärfars, Gerd, Ovesjö, Marie-Louise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351842/ https://www.ncbi.nlm.nih.gov/pubmed/32388641 http://dx.doi.org/10.1007/s00228-020-02885-1

Ejemplares similares

Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’)
por: Eriksen, Jaran, et al.
Publicado: (2017)

Intensive monitoring of duloxetine: results of a web-based intensive monitoring study
por: Härmark, Linda, et al.
Publicado: (2012)

A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues
por: Hasford, J., et al.
Publicado: (2021)

Development and pilot testing of PHARAO—a decision support system for pharmacological risk assessment in the elderly
por: Böttiger, Ylva, et al.
Publicado: (2017)

Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
por: Komen, Joris, et al.
Publicado: (2017)

The interplay of context factors in hypnotic and sedative prescription in primary and secondary care—a qualitative study
por: Weiß, Vivien, et al.
Publicado: (2018)

Medication as a risk factor for hospitalization due to heart failure and shock: a series of case-crossover studies in Swiss claims data
por: Jödicke, Annika M., et al.
Publicado: (2020)

A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study
por: Norberg, Helena, et al.
Publicado: (2020)

Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study
por: Norberg, Helena, et al.
Publicado: (2022)

Prevalence and initiation of statin therapy in the oldest old—a longitudinal population-based study
por: Sundvall, Helena, et al.
Publicado: (2022)

Ivabradine use in pregnant women—treatment indications and pregnancy outcome: an evaluation of the German Embryotox database
por: Hoeltzenbein, Maria, et al.
Publicado: (2021)

Pattern of asthma medication use among children from a large urban center in Brazil
por: Santos, Djanilson Barbosa, et al.
Publicado: (2011)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Headley, J., et al.
Publicado: (2007)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

The use of driving impairing medicines: a European survey
por: Ravera, Silvia, et al.
Publicado: (2009)

Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)

The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
por: Derijks, Hieronymus J., et al.
Publicado: (2008)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Pharmacovigilance in children in Camagüey Province, Cuba
por: Bárzaga Arencibia, Z., et al.
Publicado: (2012)

Effects of codeine on pregnancy outcome: results from a large population-based cohort study
por: Nezvalová-Henriksen, Kateřina, et al.
Publicado: (2011)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

Appropriateness of treatment recommendations for PPI in hospital discharge letters
por: Ahrens, Dirk, et al.
Publicado: (2010)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

Defining antimicrobial prescribing quality indicators: what is a new prescription?
por: Boesten, Jos, et al.
Publicado: (2010)

Do medical students copy the drug treatment choices of their teachers or do they think for themselves?
por: Tichelaar, J., et al.
Publicado: (2009)

Unintended consequences of reducing QT-alert overload in a computerized physician order entry system
por: van der Sijs, Heleen, et al.
Publicado: (2009)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Medication errors in the Middle East countries: A systematic review of the literature
por: Alsulami, Zayed, et al.
Publicado: (2012)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals
por: Ebbers, Hans C., et al.
Publicado: (2012)

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
por: Clay, Emilie, et al.
Publicado: (2012)

Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine
por: Russo, Leo, et al.
Publicado: (2014)

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area
por: Grundmark, Birgitta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t7sj5ct6j5r8j83ockaq0prc9n